Capecitabine, Oxaliplatin, Selenomethionine, and Radiation Therapy in Treating Patients Undergoing Surgery For Newly Diagnosed Stage II or III Rectal Adenocarcinoma

NCT00625183 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

5

Enrollment

OTHER

Sponsor class

Stopped Withdrawn due to poor/low accrual

Conditions

Colorectal Cancer

Interventions

DIETARY_SUPPLEMENT: selenomethionine
DRUG: capecitabine
DRUG: oxaliplatin
OTHER: laboratory biomarker analysis
OTHER: pharmacological study
PROCEDURE: adjuvant therapy
PROCEDURE: neoadjuvant therapy
PROCEDURE: therapeutic conventional surgery
RADIATION: radiation therapy

Sponsor

Roswell Park Cancer Institute

Collaborators

[object Object]